Keyphrases
Adverse Effects
100%
Scrambler Therapy
100%
Complication Rate
40%
Open-label Trial
40%
Non-invasive Neuromodulation
40%
United States
20%
Randomized Controlled Trial
20%
Meta-analysis
20%
Inclusion Criteria
20%
Order of Magnitude
20%
PubMed
20%
Embase
20%
Treatment Protocol
20%
Scopus
20%
Serious Adverse Events
20%
Systematic Meta-analysis
20%
Neuromodulation
20%
Clinical Trial Registry
20%
United States Food
20%
Cochrane Central Register of Controlled Trials
20%
U.S. National Library of Medicine
20%
Web of Science
20%
Safer Alternatives
20%
Device Implantation
20%
Drug-device
20%
Contact Dermatitis
20%
Ecchymosis
20%
Prospero
20%
Reporting Item
20%
Search Protocol
20%
Medicine and Dentistry
Adverse Event
100%
Systematic Review
100%
Neuromodulation
75%
Randomized Controlled Trial
50%
Side Effect
50%
Open-Label Trial
50%
Drug Administration
25%
Meta-Analysis
25%
Prospective Study
25%
Clinical Trial
25%
Retrospective Study
25%
Medicine
25%
Contact Dermatitis
25%
Ecchymosis
25%
Feeding
25%
Nursing and Health Professions
Adverse Event
100%
Systematic Review
100%
Side Effect
50%
Open-Label Trial
50%
Practice Guideline
25%
Meta Analysis
25%
Food and Drug Administration
25%
Cochrane Library
25%
Scopus
25%
Medline
25%
Embase
25%
Contact Dermatitis
25%
Ecchymosis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
100%
Side Effect
50%
Randomized Controlled Trial
50%
Open-Label Trial
50%
Clinical Trial
25%
Prospective Study
25%
Retrospective Study
25%
Drug Administration
25%
Contact Dermatitis
25%
Ecchymosis
25%